{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:05:01Z","timestamp":1774314301728,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-AI03904"],"award-info":[{"award-number":["R01-AI03904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Miscellaneous Donors Fund"},{"name":"Clinical and Translational Science Award","award":["RL1 TR00066"],"award-info":[{"award-number":["RL1 TR00066"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.vaccine.2016.01.017","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T11:46:27Z","timestamp":1453376787000},"page":"1480-1488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection"],"prefix":"10.1016","volume":"34","author":[{"given":"Alek M.","family":"Aranyos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon R.","family":"Roff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiyu","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James K.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet K.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.01.017_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2015.05.001","article-title":"HIV therapeutic vaccines: moving towards a functional cure","volume":"35","author":"Mylvaganam","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2016.01.017_bib0190","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fimmu.2014.00417","article-title":"Challenges in HIV vaccine research for treatment and prevention","volume":"5","author":"Ensoli","year":"2014","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.017_bib0195","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharma.2014.11.003","article-title":"Understanding HIV infection for the design of a therapeutic vaccine, Part II: vaccination strategies for HIV","volume":"73","author":"de Goede","year":"2015","journal-title":"Ann Pharm Fran\u00e7aises"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.017_bib0200","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2012.01.014","article-title":"Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation","volume":"36","author":"Shan","year":"2012","journal-title":"Immunity"},{"issue":"52","key":"10.1016\/j.vaccine.2016.01.017_bib0205","article-title":"Do HIV-specific CTL continue to have an antiviral function during antiretroviral therapy? If no, why not, and what can be done about it?","volume":"4","author":"Mcllroy","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2016.01.017_bib0210","doi-asserted-by":"crossref","unstructured":"Siliciano RF. Targeting reservoirs to clear and cure. Nat. Med 20(5): 480-481.","DOI":"10.1038\/nm.3550"},{"issue":"9653","key":"10.1016\/j.vaccine.2016.01.017_bib0215","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.01.017_bib0220","series-title":"Cellular and molecular immunology","first-page":"215","article-title":"B cell activation and antibody production","author":"Abbas","year":"2010"},{"key":"10.1016\/j.vaccine.2016.01.017_bib0225","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2174\/1874613601206010274","article-title":"HIV-1 vaccine trials: evolving concepts and designs","volume":"6","author":"Sanou","year":"2012","journal-title":"Open AIDS J"},{"issue":"5359","key":"10.1016\/j.vaccine.2016.01.017_bib0230","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1126\/science.279.5359.2103","article-title":"Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA","volume":"279","author":"Ogg","year":"1998","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.vaccine.2016.01.017_bib0235","doi-asserted-by":"crossref","first-page":"11983","DOI":"10.1128\/JVI.75.24.11983-11991.2001","article-title":"Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection","volume":"75","author":"Betts","year":"2001","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.017_bib0240","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1128\/jvi.76.5.2298-2305.2002","article-title":"Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma","volume":"76","author":"Edwards","year":"2002","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2016.01.017_bib0245","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.189.6.991","article-title":"Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques","volume":"89","author":"Jin","year":"1999","journal-title":"J Exp Med"},{"issue":"5403","key":"10.1016\/j.vaccine.2016.01.017_bib0250","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes","volume":"283","author":"Schmitz","year":"1999","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.vaccine.2016.01.017_bib0255","doi-asserted-by":"crossref","first-page":"e44778","DOI":"10.1371\/journal.pone.0044778","article-title":"Biologically-directed modeling reflects cytolytic clearance of SIV-infected cells in vivo in macaques","volume":"7","author":"Wick","year":"2012","journal-title":"PLoS One"},{"issue":"469","key":"10.1016\/j.vaccine.2016.01.017_bib0260","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature12519","article-title":"Immune clearance of highly pathogenic SIV infection","volume":"502","author":"Hansen","year":"2013","journal-title":"Nature"},{"issue":"6135","key":"10.1016\/j.vaccine.2016.01.017_bib0265","doi-asserted-by":"crossref","first-page":"1237874","DOI":"10.1126\/science.1237874","article-title":"Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms","volume":"340","author":"Hansen","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.017_bib0270","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1006\/cimm.1999.1574","article-title":"MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors","volume":"198","author":"Pu","year":"1999","journal-title":"Cell Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.017_bib0275","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.vaccine.2004.05.032","article-title":"Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine","volume":"23","author":"Omori","year":"2004","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.01.017_bib0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.vetimm.2008.01.030","article-title":"Advances in FIV vaccine technology","volume":"123","author":"Uhl","year":"2008","journal-title":"Vet Immunol Immunopathol"},{"issue":"6","key":"10.1016\/j.vaccine.2016.01.017_bib0285","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.vaccine.2013.05.024","article-title":"Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.017_bib0290","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","article-title":"Pathways of antigen processing","volume":"31","author":"Blum","year":"2013","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.017_bib0295","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/157016210790416361","article-title":"Feline immunodeficiency virus model for designing HIV\/AIDS vaccines","volume":"8","author":"Yamamoto","year":"2010","journal-title":"Curr HIV Res"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.017_bib0300","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00007890-199708150-00022","article-title":"Fractionation of feline bone marrow with the soybean agglutinin lectin yields populations enriched for erythroid and myeloid elements: transplantation of soybean agglutinin-negative cells into lethally irradiated recipients","volume":"64","author":"Gengozian","year":"1997","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.vaccine.2016.01.017_bib0305","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1128\/JVI.70.8.5165-5169.1996","article-title":"Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node","volume":"70","author":"Dean","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.01.017_bib0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2015.04.002","article-title":"Moroccan study of HLA (-A, -B, -C, -DR, -DQ) polymorphism in 647 unrelated controls: updating data","author":"Brick","year":"2015","journal-title":"Mol Cell Probes"},{"issue":"14","key":"10.1016\/j.vaccine.2016.01.017_bib0315","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/01.aids.0000183627.81922.be","article-title":"HIV-1 p24 vaccine protects cats against feline immunodeficiency virus infection","volume":"19","author":"Coleman","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2016.01.017_bib0320","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-61779-325-7_4","article-title":"Utilization of feline ELISPOT for mapping vaccine epitopes","volume":"792","author":"Abbott","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2016.01.017_bib0325","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2015.1026500","article-title":"Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects","volume":"11","author":"Roff","year":"2015","journal-title":"Hum Vaccines Immunother"},{"issue":"11","key":"10.1016\/j.vaccine.2016.01.017_bib0330","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1089\/aid.1991.7.911","article-title":"Experimental vaccine protection against feline immunodeficiency virus","volume":"7","author":"Yamamoto","year":"1991","journal-title":"AIDS Res Human Retrovir"},{"issue":"8","key":"10.1016\/j.vaccine.2016.01.017_bib0335","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.vaccine.2015.01.028","article-title":"Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine","volume":"33","author":"Beczkowski","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.017_bib0340","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1128\/JVI.02638-09","article-title":"Env-expressing autologous T lymphocytes Induce neutralizing antibody and afford marked protection against feline immunodeficiency virus","author":"Pistello","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.01.017_bib0345","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/JVI.70.1.617-622.1996","article-title":"Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies","author":"Matteucci","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.01.017_bib0350","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1128\/JVI.72.9.7310-7319.1998","article-title":"DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies","volume":"72","author":"Hosie","year":"1998","journal-title":"J Virol"},{"issue":"23","key":"10.1016\/j.vaccine.2016.01.017_bib0355","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2016.01.017_bib0360","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.4049\/jimmunol.1102756","article-title":"The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope","volume":"188","author":"de Souza","year":"2012","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T06:20:08Z","timestamp":1600064408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16000438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0264410X16000438"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}